Dr. Kasmintan Schrader is an Assistant Professor, Clinician-Scientist, Medical Geneticist who received her PhD in Pathology and Laboratory Medicine at the University of British Columbia. She trained in cancer susceptibility gene discovery at Memorial Sloan Kettering in New York and returned to BC in 2014 to build the Familial Pancreatic Cancer Program. In 2016, she became Co-Medical Director of BC Cancer's Hereditary Cancer Program and in 2021 was awarded a Tier 2 Canada Research Chair in Clinical Cancer Genetics and Genomics. Dr. Schrader investigates the utility of germline variation in overall cancer care and prevention; in order to harness precision oncology for the benefit of patients and families. ​